(Q35103872)

English

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors

scholarly article

Statements

Radiolabeled somatostatin receptor antagonists are preferable to agonists for in vivo peptide receptor targeting of tumors (English)
20 October 2006
16436-16441

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit